All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]
L Degos(Centre Hospitalier Universitaire de Lille), Pierre Fenaux(Saint Louis University Hospital), JM Micléa, Claude Chastang(European Union), Sylvie Castaigné(Hôpital André Mignot), Hervé Dombret(University of London Institute in Paris), M‐T. Daniel(Centre Hospitalier Universitaire de Lille), Christine Chomienne(Inserm)
Cited by 373
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k